stockrowOmnicell, Inc. (OMCL) vs Schrodinger, Inc. (SDGR)
- Omnicell, Inc. OMCL 37.33 −1.84%
- Schrodinger, Inc. SDGR 29.96 +4.14%
Omnicell, Inc. and Schrodinger, Inc. are both Health Information Services companies. Schrodinger, Inc. is the larger, with a market value of $2.2B against $1.7B — 1.2× the size. Schrodinger, Inc. has negative trailing earnings, so its P/E is not meaningful; Omnicell, Inc. trades at 39.0×. Omnicell, Inc. grew revenue faster over the last twelve months: 5.62% against 4.77%. Omnicell, Inc. has the higher net margin (3.59% vs −22.0%) and the higher return on invested capital (3.45% vs 0.00%). Across the 19 metrics below, Omnicell, Inc. leads on 13 and Schrodinger, Inc. on 6.
Valuation
Profitability
| Metric | OMCL | SDGR | Health Information Services median |
|---|---|---|---|
| Gross margin | 45.14% | 58.52% | 59.61% |
| Operating margin | 5.20% | (49.64%) | (10.54%) |
| Net margin | 3.59% | (22.01%) | (16.14%) |
| Free cash flow margin | 10.67% | (43.38%) | 0.00% |
| Return on equity | 0.00% | (19.02%) | (3.15%) |
| Return on assets | 2.23% | (9.36%) | (5.62%) |
| Return on invested capital | 3.45% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack